What’s Wrong With Kimberly-Clark Stock?
Kimberly-Clark has been facing several challenges.
Does Marijuana Rescheduling Really Help Tilray’s Stock?
Earlier this year, the U.S. government announced it would reclassify certain medical cannabis products from Schedule I to Schedule III substances.
AI Is Creating a Power Crisis. Constellation Energy Just Showed How It Plans to Cash In.
AI is still desperate for new energy sources despite a recent correction.
This Vanguard ETF Has Outperformed the S&P 500 and Nasdaq Composite
A Vanguard ETF that isn't on most people's radars has been outperforming the two most well-known benchmarks.
2 Dividend Kings Worth Buying and 1 Whose Streak Has Become a Liability
Dividend Kings typically provide growing streams of reliable income, but investors must watch the trajectory of these businesses.
Nasdaq Market Correction: History Is Clear About What Happens Next
The Nasdaq Composite recently entered correction territory, but history says the growth-focused index could rebound quickly.
Alphabet, Meta, and Oracle Are All Teaming Up to Disrupt Nvidia’s Biggest Competitive Advantage
The biggest factor locking customers into Nvidia chips -- the dominance of its proprietary CUDA software platform -- is under threat.
